M Teresa B Valenzuela
Affiliation: Universidad de Los Andes
- Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facilityM Teresa B Valenzuela
Medical School of Public Health, University of Los Andes, Las Condes, Santiago, Chile
Braz J Infect Dis 11:322-6. 2007..The results thus support the benefits of this pneumococcal vaccine in this elderly population who are at increased risk of invasive pneumococcal disease...
- The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidenceMaria Teresa Valenzuela
Universidad de Los Andes, Salud Pública y Epidemiología, San Carlos de Apoquindo, Santiago, Chile
Rev Panam Salud Publica 25:270-9. 2009..To conduct a comprehensive review of data on pneumococcal disease incidence in Latin America and the Caribbean and project the annual number of pneumococcal disease episodes and deaths among children < 5 years of age in the region...
- Antibiotic resistance in Latin America: a cause for alarmM Teresa Valenzuela
Department of Public Health and Epidemiology, Universidad de Los Andes, Santiago, Chile
Vaccine 27:C25-8. 2009..Existing surveillance systems must be continued to recognise changes in patterns of resistance and the serotypes that cause pneumococcal disease...
- [Vaccines against hepatitis A and B in Chile]M Teresa Valenzuela
Departamento de Salud Pública y Epidemiología, Universidad de Los Andes, Santiago, Chile
Rev Med Chil 137:844-51. 2009..If Chilean health authorities pretend to reach the enteric disease indicators of developed countries, they must accelerate the epidemiological transition towards the elimination of hepatitis A...